T H 2 and T H 17 inflammatory pathways are reciprocally regulated in asthma
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Increasing evidence suggests that asthma is a heterogeneous disorder regulated by distinct molecular mechanisms. In a cross-sectional study of asthmatics of varying severity (n = 51), endobronchial tissue gene expression analysis revealed three major patient clusters: TH2-high, TH17-high, and TH2/17-low. TH2-high and TH17-high patterns were mutually exclusive in individual patient samples, and their gene signatures were inversely correlated and differentially regulated by interleukin-13 (IL-13) and IL-17A. To understand this dichotomous pattern of T helper 2 (TH2) and TH17 signatures, we investigated the potential of type 2 cytokine suppression in promoting TH17 responses in a preclinical model of allergen-induced asthma. Neutralization of IL-4 and/or IL-13 resulted in increased TH17 cells and neutrophilic inflammation in the lung. However, neutralization of IL-13 and IL-17 protected mice from eosinophilia, mucus hyperplasia, and airway hyperreactivity and abolished the neutrophilic inflammation, suggesting that combination therapies targeting both pathways may maximize therapeutic efficacy across a patient population comprising both TH2 and TH17 endotypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The data summarized above suggest that targeting JAK and STAT3 with small-molecule inhibitors may provide a superior anti-asthma treatment approach compared with standard therapies as, they would target both Th2- and Th17-associated asthmas (Choy et al., 2015).”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Choy et al., 2015
In the citing paper
“almost all murine models of intestinal fibrosis are influenced by the microbiota154”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [154]
Citations
Cites
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R., & Program, G. I. F. A. (. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00526.x · Cited by 3,529
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
British Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,021
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871 · cited 1×
“Identifying the molecular mechanisms driving subtypes of asthma has the potential to reveal drug targets, biomarkers to predict treatment response, and appropriately target therapy, as evidenced by recent clinical studies of T helper 2 (TH2) cytokine antagonists (8, 9).”
BackgroundSelf-citationThe development of allergic inflammation
Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008) · Nature · doi:10.1038/nature07204 · Cited by 1,839
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803 · cited 6×
“SERPINB2, CLCA1, and POSTN were used as IL-13–responsive TH2 signature genes as described previously (25, 26).”
BackgroundMethodInfluentialSelf-citationAsthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Self-citationLebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Self-citationTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Cited by
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Self-citationPapi, A., Brightling, C., Pedersen, S. E., & Reddel, H. K. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33311-1 · Cited by 1,759
Inflammation and metabolism in tissue repair and regeneration
Eming, S. A., Wynn, T. A., & Martin, P. (2017) · Science · doi:10.1126/science.aam7928 · Cited by 1,369
Self-citationThe basic immunology of asthma
Hammad, H., & Lambrecht, B. N. (2021) · Cell · doi:10.1016/j.cell.2021.02.016 · Cited by 1,105
Lambrecht, B. N., Hammad, H., & Fahy, J. V. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.018 · Cited by 1,039
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
Self-citationAkdis, C. A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00538-7 · Cited by 981
Air pollution and its effects on the immune system
Glencross, D. A., Ho, T.-R., Camiña, N., Hawrylowicz, C. M., & Pfeffer, P. E. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.179 · Cited by 726
Holgate, S. T., Wenzel, S., Postma, D. S., Weiss, S. T., Renz, H., & Sly, P. D. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.25 · Cited by 652
Mack, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 514
EFSA Panel on Food Contact Materials, E. A. P. A. (., Lambré, C., Barat Baviera, J. M., Bolognesi, C., Chesson, A., Cocconcelli, P. S., Crebelli, R., Gott, D. M., Grob, K., Lampi, E., et al. (2023) · EFSA Journal · doi:10.2903/j.efsa.2023.6857 · Cited by 397
Hough, K. P., Curtiss, M. L., Blain, T. J., Liu, R.-M., Trevor, J., Deshane, J. S., & Thannickal, V. J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00191 · Cited by 432
“Notably, T helper type 2 (Th2) and Th17 cells produce cytokines that promote airway inflammation and remodeling in allergic asthma (123, 124).”
BackgroundCD4 + T-cell subsets in inflammatory diseases: beyond the T h 1/T h 2 paradigm
Hirahara, K., & Nakayama, T. (2016) · International Immunology · doi:10.1093/intimm/dxw006 · Cited by 417
Robinson, D., Humbert, M., Buhl, R., Cruz, A. A., Inoue, H., Korom, S., Hanania, N. A., & Nair, P. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12880 · Cited by 357
Eosinophilic and Noneosinophilic Asthma
Carr, T. F., Zeki, A. A., & Kraft, M. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201611-2232pp · Cited by 351
“The presence of type 2 cytokines may inhibit production of IL-8 and thus abrogate the development of neutrophilia despite the presence of Th17-type inflammation (89, 120).”
BackgroundBharadwaj, U., Kasembeli, M. M., Robinson, P., & Tweardy, D. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018440 · Cited by 314
“The data summarized above suggest that targeting JAK and STAT3 with smallmolecule inhibitors may provide a superior anti-asthma treatment approach compared with standard therapies as, they would target both Th2- and Th17-associated asthmas (Choy et al., 2015).”
BackgroundWang, Z., Locantore, N., Haldar, K., Ramsheh, M. Y., Beech, A. S., Ma, W., Brown, J. R., Tal-Singer, R., Barer, M. R., Bafadhel, M., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3448oc · Cited by 274
“The biology underlying this dynamism is uncertain, but it has been shown that therapeutic blockade of Th2 cytokines enhances Th17 inflammation in asthma (49), suggesting that ICS treatment may contribute to the endotypic switches.”
BackgroundMechanisms and therapeutic strategies for non‐T2 asthma
Sze, E., Bhalla, A., & Nair, P. (2020) · Allergy · doi:10.1111/all.13985 · Cited by 259
Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation
Sanyal, R. D., Pavel, A. B., Glickman, J., Chan, T. C., Zheng, X., Zhang, N., Cueto, I., Peng, X., Estrada, Y., Fuentes-Duculan, J., et al. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.08.024 · Cited by 207
Toward clinically applicable biomarkers for asthma: An EAACI position paper
Diamant, Z., Vijverberg, S., Alving, K., Bakirtas, A., Bjermer, L., Custovic, A., Dahlen, S., Gaga, M., Gerth van Wijk, R., Del Giacco, S., et al. (2019) · Allergy · doi:10.1111/all.13806 · Cited by 201
Self-citationIL-17 in the lung: the good, the bad, and the ugly
Gurczynski, S. J., & Moore, B. B. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00344.2017 · Cited by 202
Cockroach allergen exposure and risk of asthma
Do, D. C., Zhao, Y., & Gao, P. (2016) · Allergy · doi:10.1111/all.12827 · Cited by 189
Agache, I., & Akdis, C. A. (2016) · Allergology International · doi:10.1016/j.alit.2016.04.011 · Cited by 195
Kasembeli, M. M., Bharadwaj, U., Robinson, P., & Tweardy, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082299 · Cited by 199
“Available data suggest there may be a therapeutic advantage of targeting both Th2 and Th17 in asthma to maximize therapeutic efficacy [69], which C188-9 may be able to provide.”
BackgroundLong-Term Therapy Response to Anti–IL-5 Biologics in Severe Asthma—A Real-Life Evaluation
Eger, K., Kroes, J. A., ten Brinke, A., & Bel, E. H. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.10.010 · Cited by 180
The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
Marone, G., Granata, F., Pucino, V., Pecoraro, A., Heffler, E., Loffredo, S., Scadding, G. W., & Varricchi, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01387 · Cited by 171
Chen, K., & Kolls, J. K. (2017) · Gene · doi:10.1016/j.gene.2017.01.016 · Cited by 164
“Heterogeneous expression of IL-13 (Th2 signature cytokine) and IL-17 (Th17 signature cytokine) related genes have been observed in both patients and animal models, suggesting combination therapy targeting both pathways could be effective in treating asthma (Choy et al., 2015).”
BackgroundMacrophage dysfunction in the pathogenesis and treatment of asthma
Fricker, M., & Gibson, P. G. (2017) · European Respiratory Journal · doi:10.1183/13993003.00196-2017 · Cited by 169
Distinct spatial and temporal roles for Th1, Th2, and Th17 cells in asthma
Luo, W., Hu, J., Xu, W., & Dong, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974066 · Cited by 193
“The eosinophilic inflammation in the airway mediated by Th2 cells could be attenuated by the administration of pro-Th1 or Th17associated cytokines, including IL-12 and IL-17 (1, 2).”
BackgroundResultPathogenesis of asthma: implications for precision medicine
RUSSELL, R. J., & Brightling, C. E. (2017) · Clinical Science · doi:10.1042/cs20160253 · Cited by 175
Alternative splicing of interleukin-33 and type 2 inflammation in asthma
Gordon, E. D., Simpson, L. J., Rios, C. L., Ringel, L., Lachowicz-Scroggins, M. E., Peters, M. C., Wesolowska-Andersen, A., Gonzalez, J. R., MacLeod, H. J., Christian, L. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601914113 · Cited by 153
“Although subgroups of asthmatics with neutrophilic airway inflammation have been described (45, 46), it will be important to understand whether these or other associated cell types may be suppressing type 2 responses and promoting alternative inflammatory pathways in asthma.”
BackgroundT2-“Low” Asthma: Overview and Management Strategies
Fitzpatrick, A. M., Chipps, B. E., Holguín, F., & Woodruff, P. G. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.11.006 · Cited by 170
Airway hyperresponsiveness in asthma: The role of the epithelium
Bradding, P., Porsbjerg, C. M., Côté, A., Dahlén, S., Hallstrand, T. S., & Brightling, C. E. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.02.011 · Cited by 167
Self-citationRole of IL-17 in asthma pathogenesis and its implications for the clinic
Ramakrishnan, R. K., Heialy, S. A., & Hamid, Q. A. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1666002 · Cited by 154
Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes
Wenzel, S. E. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3631ci · Cited by 166
“The presence of neutrophils has been linked to Th17, inflammasome, and IL-6 pathways, with little overlap with T2 pathways (32, 99, 101).”
BackgroundMechanism of TH2/TH17-predominant and neutrophilic TH2/TH17-low subtypes of asthma
Liu, W., Liu, S., Verma, M., Zafar, I., Good, J. T., Rollins, D. R., Groshong, S., Gorska, M. M., Martin, R. J., & Alam, R. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.032 · Cited by 152
The Dynamic Interplay Between Cardiac Inflammation and Fibrosis
Thomas, T. P., & Grisanti, L. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.529075 · Cited by 167
Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis
Kokubo, K., Onodera, A., Kiuchi, M., Tsuji, K., Hirahara, K., & Nakayama, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945063 · Cited by 167
Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation
Li, J., Casanova, J.-L., & Puel, A. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.97 · Cited by 146
Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study
Loza, M. J., Djukanović, R., Chung, K. F., Horowitz, D. M., Ma, K., Branigan, P. J., Barnathan, E. S., Susulic, V. S., Silkoff, P. E., Sterk, P. J., et al. (2016) · Respiratory Research · doi:10.1186/s12931-016-0482-9 · Cited by 143
“[28] in mild asthma (evaluating T2 phenotype status by POSTN, SERPINB2, and CLCA1 expression in endo-”
BackgroundTH17 cells and corticosteroid insensitivity in severe asthma
Xie, Y., Abel, P. W., Casale, T. B., & Tu, Y. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.12.769 · Cited by 151
Allergic airway inflammation: key players beyond the Th2 cell pathway
Hirose, K., Iwata, A., Tamachi, T., & Nakajima, H. (2017) · Immunological Reviews · doi:10.1111/imr.12540 · Cited by 146
Gieseck, R. L., Ramalingam, T. R., Hart, K. M., Vannella, K. M., Cantu, D. A., Lu, W.-Y., Ferreira-González, S., Forbes, S. J., Vallier, L., & Wynn, T. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.009 · Cited by 132
“…149 affecting multiple organ systems including idiopathic pulmonary fibrosis (IPF) (Chandriani et 150 al., 2014; Murray et al., 2014), asthma (Choy et al., 2015; Scheerens et al., 2014), atopic 151 dermatitis (Metwally et al., 2004), and ulcerative colitis (UC) (Heller et al., 2005), among…”
Self-citationThe Human Microbiota and Asthma
Ver Heul, A., Planer, J., & Kau, A. L. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8719-7 · Cited by 125
The Airway Epithelium—A Central Player in Asthma Pathogenesis
Calvén, J., Ax, E., & Rådinger, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238907 · Cited by 139
Malik, K., He, H., Huynh, T. N., Tran, G., Mueller, K. A., Doytcheva, K., Renert‐Yuval, Y., Czarnowicki, T., Magidi, S., Chou, M. M., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.021 · Cited by 140
Woytschak, J., Keller, N., Krieg, C., Impellizzieri, D., Thompson, R. W., Wynn, T. A., Zinkernagel, A. S., & Boyman, O. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.025 · Cited by 136
“Also, in animals sensitized with house dust mite extract, inhibition of IL-4 by using a neutralizing anti-IL-4 mAb leads to increased neutrophil counts in the lungs (Choy et al., 2015).”
BackgroundSelf-citationRisankizumab in Severe Asthma — A Phase 2a, Placebo-Controlled Trial
Brightling, C. E., Nair, P. K., Cousins, D. J., Louis, R. E., & Singh, D. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2030880 · Cited by 131
IL-17–high asthma with features of a psoriasis immunophenotype
Östling, J., van Geest, M., Schofield, J. P. R., Jevnikar, Z., Wilson, S. J., Ward, J., Lutter, R., Shaw, D. E., Bakke, P. S., Caruso, M., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.03.027 · Cited by 128
“In a study of 51 asthmatic patients with a range of clinical severities, Choy et al12 identified a group characterized by high expression of genes in the bronchial epithelium demonstrated to be upregulated in vitro by IL-17A.12 In these patients epithelial T17 and T2 gene signatures were inversely correlated, suggesti…”
BackgroundHarker, J. A., & Lloyd, C. M. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221094 · Cited by 134
Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma?
Ray, A., Camiolo, M. J., Fitzpatrick, A. M., Gauthier, M. C., & Wenzel, S. E. (2020) · Physiological Reviews · doi:10.1152/physrev.00023.2019 · Cited by 128
Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood
Czarnowicki, T., He, H., Canter, T., Han, J., Lefferdink, R., Erickson, T., Rangel, S., Kameyama, N., Kim, H. J., Pavel, A. B., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.09.031 · Cited by 118
Gavino, A. C., Nahmod, K., Bharadwaj, U., Makedonas, G., & Tweardy, D. J. (2016) · Allergy · doi:10.1111/all.12937 · Cited by 114
“Blocking both Th2 and Th17 pathways in mouse asthma models recently has been shown to be more effective in reducing lung inflammation compared to blocking one pathway alone, in part, by preventing compensatory over activity of the reciprocal pathway (24).”
BackgroundPathogenic CD4+ T cells in patients with asthma
Muehling, L. M., Lawrence, M. G., & Woodfolk, J. A. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.02.025 · Cited by 120
Recent developments and highlights in biomarkers in allergic diseases and asthma
Eguíluz‐Gracia, I., Tay, T. R., Hew, M. J., Escribese, M. M., Barber, D., O’Hehir, R. E., & Torres, M. J. (2018) · Allergy · doi:10.1111/all.13628 · Cited by 120
“Interestingly, a different study found that Th2 and Th17 gene expression signatures were mutually exclusive in asthmatic airway tissue.(59) The authors suggested that suppression of Th2 activity by corticosteroids may”
BackgroundAutoimmune Responses in Severe Asthma
Mukherjee, M., & Nair, P. K. (2018) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2018.10.5.428 · Cited by 115
Christenson, S. A., van den Berge, M., Faiz, A., Inkamp, K., Bhakta, N. R., Bonser, L. R., Zlock, L. T., Barjaktarević, I., Barr, R. G., Bleecker, E. R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121087 · Cited by 117
Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function
Andersson, C. K., Adams, A., Nagakumar, P., Bossley, C. J., Gupta, A., Vries, D. D., Adnan, A., Bush, A., Saglani, S., & Lloyd, C. M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.022 · Cited by 113
Leveraging -omics for asthma endotyping
Tyler, S. R., & Bunyavanich, S. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.05.015 · Cited by 117
Frøssing, L., Silberbrandt, A. W., von Bülow, A., Backer, V., & Porsbjerg, C. M. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.09.051 · Cited by 117
Different endotypes and phenotypes drive the heterogeneity in severe asthma
McDowell, P. J., & Heaney, L. G. (2019) · Allergy · doi:10.1111/all.13966 · Cited by 108
Self-citationNovel approaches to the management of noneosinophilic asthma
Thomson, N. C. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465816632638 · Cited by 110
“com 217 contribute to the development of Th17-high neutrophilic inflammation [Choy et al. 2015; Shum, 2015].”
BackgroundT2-low asthma: current approach to diagnosis and therapy
Samitas, Κ., Ζervas, Ε., & Gaga, M. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000342 · Cited by 113
Multitissue Transcriptomics Delineates the Diversity of Airway T Cell Functions in Asthma
Singhania, A., Wallington, J. C., Smith, C. G., Horowitz, D., Staples, K. J., Howarth, P. H., Gadola, S. D., Djukanović, R., Woelk, C. H., & Hinks, T. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0162oc · Cited by 110
“The critical role of T-helper cells type 2 (Th2), producing type 2 cytokines, has long been appreciated, but there is an emerging recognition of a wide variety of novel T cell subsets and innate-like lymphocytes producing a diversity of cytokines, many of which may be steroid resistant (3, 4).”
BackgroundInfluentialPrecision medicine for the discovery of treatable mechanisms in severe asthma
Chung, K. F., & Adcock, I. M. (2019) · Allergy · doi:10.1111/all.13771 · Cited by 105
Bradding, P., Richardson, M., Hinks, T., Howarth, P. H., Choy, D. F., Arron, J. R., Wenzel, S. E., & Siddiqui, S. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.013 · Cited by 98
Self-citationPeanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells
Monian, B., Tu, A. A., Ruiter, B., Morgan, D. M., Petrossian, P. M., Smith, N. P., Gierahn, T. M., Ginder, J. H., Shreffler, W. G., & Love, J. C. (2022) · Journal of Clinical Investigation · doi:10.1172/jci150634 · Cited by 100
Update on regulation and effector functions of Th17 cells
Sandquist, I., & Kolls, J. (2018) · F1000Research · doi:10.12688/f1000research.13020.1 · Cited by 91
Influenza A Virus Infection Causes Chronic Lung Disease Linked to Sites of Active Viral RNA Remnants
Keeler, S. P., Agapov, E. V., Hinojosa, M. E., Letvin, A. N., Wu, K., & Holtzman, M. J. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800671 · Cited by 98
Formononetin Attenuates Airway Inflammation and Oxidative Stress in Murine Allergic Asthma
Yi, L., Cui, J., Wang, W., Tang, W., Teng, F., Zhu, X., Qin, J., Wuniqiemu, T., Sun, J., Wei, Y., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.533841 · Cited by 98
“Some studies reported that Th2 and Th17 inflammation aremutually regulated in asthma, and suppression of Th2 cytokines promotes Th17 response, indicating that combination therapies inhibiting both inflammation patterns may exert optimal efficacy in asthma managements (Choy et al., 2015; Liu et al., 2017).”
BackgroundThe role of interleukin-17 in asthma: a protective response?
Hynes, G., & Hinks, T. (2020) · ERJ Open Research · doi:10.1183/23120541.00364-2019 · Cited by 103
Personalized medicine with biologics for severe type 2 asthma: current status and future prospects
Godar, M., Blanchetot, C., de Haard, H., Lambrecht, B. N., & Brusselle, G. (2017) · mAbs · doi:10.1080/19420862.2017.1392425 · Cited by 99
“However, neutralization of IL-13 and IL-17 protected mice from eosinophilia, mucus hyperplasia, airway hyperreactivity and abolished the neutrophilic inflammation, which suggests that combination therapies targeting both pathways may maximize therapeutic efficacy across a patient population comprising both type 2 and…”
BackgroundInfluentialImpellizzieri, D., Ridder, F., Raeber, M. E., Egholm, C., Woytschak, J., Kolios, A. G. A., Legler, D. F., & Boyman, O. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.01.042 · Cited by 87
Elesela, S., Morris, S. B., Narayanan, S., Kumar, S., Lombard, D. B., & Lukacs, N. W. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008319 · Cited by 97
Dendritic cells in lung immunopathology
Cook, P. C., & MacDonald, A. S. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0571-3 · Cited by 98
“However, in recent years, as patient stratification approaches have become more refined, it has become clear that asthma is not a single disease and that individuals with asthma can be further classified into distinct groups or ‘endotypes’ [10].”
BackgroundTissue-specific immunity in helminth infections
Vacca, F., & Le Gros, G. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00531-w · Cited by 86
Mast cells and their activation in lung disease
Virk, H. S., Arthur, G. K., & Bradding, P. (2016) · Translational research · doi:10.1016/j.trsl.2016.01.005 · Cited by 102
Self-citationHe, H., Li, R., Choi, S., Zhou, L., Pavel, A., Estrada, Y. D., Krueger, J. G., & Guttman-Yassky, E. (2020) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2019.10.013 · Cited by 87
Andreev, D., Liu, M., Kachler, K., Perez, M. L., Kirchner, P., Koelle, J., Gießl, A., Rauber, S., Song, R., Aust, O., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218902 · Cited by 97
Su, L., Mao, C., Wang, X., Li, L., Tong, H., Mao, J., Ji, D., Lu, T., Hao, M., Huang, Z., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.519479 · Cited by 92
“Th2 cells can also be regulated by the transcription factor GATA3 and secrete IL-4, IL-5, IL-13 and other effector cytokines to regulate allergic reaction (Choy et al., 2015).”
BackgroundBorish, L. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.04.022 · Cited by 87
Mei, M., Song, H., Chen, L., Hu, B., Bai, R., Xu, D., Liu, Y., Zhao, Y., & Chen, C. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0249-1 · Cited by 83
“We also found that the gene expression of neutrophil chemoattractants, including CXCL1 and CXCL2, which are inducible by IL-17A and regarded as Th17 signature genes [34], was increased in the lungs of adult mice that had once been exposed to PM as juveniles.”
BackgroundNew Targeted Therapies for Uncontrolled Asthma.
Corren, J. (2019) · Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.03.022 · Cited by 73
Precision medicine in asthma: linking phenotypes to targeted treatments
Chung, K. F. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000434 · Cited by 95
Maeda, K., Caldez, M. J., & Akira, S. (2019) · Allergy · doi:10.1111/all.13788 · Cited by 83
Role of Autophagy in Lung Inflammation
Painter, J. D., Galle-Treger, L., & Akbari, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01337 · Cited by 84
Xie, C. H., Yang, J., Gul, A., Li, Y., Zhang, R., Yalikun, M., Lv, X., Lin, Y., Luo, Q., & Gao, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1478624 · Cited by 88
“…a study suggested that the T H 2 and T H 17 in fl ammatory pathways are mutually regulated in patients with asthma; the suppression of the T H 2 pathway promotes a T H 17 response; therefore, the dual blockade of T H 2 and T H 17 functionalities may be rewarding for asthma treatment (134).”
BackgroundMuñoz, X., Barreiro, E., Bustamante, V., López-Campos, J. L., González‐Barcala, F. J., & Cruz, M. J. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.10.188 · Cited by 86
Hall, S. L., Baker, T. A., Lajoie, S., Richgels, P. K., Yang, Y., McAlees, J. W., van Lier, A. G., Wills-Karp, M. A., Sivaprasad, U., Acciani, T. H., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.037 · Cited by 81
Serum Levels of Eosinophil-Derived Neurotoxin: A Biomarker for Asthma Severity in Adult Asthmatics
Lee, Y., Lee, J.-H., Yang, E., Kwon, E., Jung, C., Kim, S.-C., Choi, Y., Cho, Y. S., Kim, C. K., & Park, H. (2019) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2019.11.3.394 · Cited by 80
Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell
Olsthoorn, S. E. M., van Krimpen, A., Hendriks, R. W., & Stadhouders, R. (2025) · Immunological Reviews · doi:10.1111/imr.70010 · Cited by 85
“In apparent contrast, Choy et al. observed a negative correlation between the expression of Th2-and Th17-associated gene signatures in bronchial biopsies of 51 asthma patients [291].”
Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis
Ryu, G., & Kim, D. W. (2019) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000588 · Cited by 77
“In a murine asthma model, blockade ofTh2 cytokines, such as IL-4/IL-23 induced compensatory Th17 inflammation [77].”
BackgroundPhenotype overlap in the natural history of asthma
Ricciardolo, F. L. M., Guida, G., Bertolini, F., Stefano, A. D., & Carriero, V. M. A. (2023) · European Respiratory Review · doi:10.1183/16000617.0201-2022 · Cited by 77
Pandya, J. M., Lundell, A., Hallström, M., Andersson, K. M., Nordström, I., & Rudin, A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0116-025r · Cited by 77
“, Th2, Th17, and Th2/Th17), but not a group with high expression of both Th2 and Th17, which shows that these cell types are mutually exclusive [47].”
BackgroundMyosin light chains 9 and 12 are functional ligands for CD69 that regulate airway inflammation
Hayashizaki, K., Kimura, M. Y., Tokoyoda, K., Hosokawa, H., Shinoda, K., Hirahara, K., Ichikawa, T., Onodera, A., Hanazawa, A., Iwamura, C., et al. (2016) · Science Immunology · doi:10.1126/sciimmunol.aaf9154 · Cited by 77
HSP90 inhibitor geldanamycin reverts IL-13– and IL-17–induced airway goblet cell metaplasia
Pezzulo, A. A., Tudas, R. A., Stewart, C. G., Buonfiglio, L. G. V., Lindsay, B. D., Taft, P. J., Gansemer, N. D., & Zabner, J. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123524 · Cited by 77
Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis
Hams, E., Bermingham, R., & Fallon, P. G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00597 · Cited by 75
“Experimental models have shown that therapeutically targeting one cluster promotes the other subtype and that combination therapy may prove more effective (67).”
BackgroundSilkoff, P. E., Laviolette, M., Singh, D., FitzGerald, J. M., Kelsen, S. G., Backer, V., Porsbjerg, C. M., Girodet, P., Berger, P., Kline, J. N., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.11.038 · Cited by 73
A Network of Sputum MicroRNAs Is Associated with Neutrophilic Airway Inflammation in Asthma
Gómez, J. L., Chen, A., Diaz, M. P., Zirn, N., Gupta, A., Britto, C. J., Sauler, M., Yan, X., Stewart, E., Santerian, K., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201912-2360oc · Cited by 70
“Together, these data support an association between blue module microRNAs, especially hsa-miR223-3p, and airway neutrophilia, in addition to IL-17 expression in the airway, suggesting a potential effect of IL-17 in neutrophil recruitment to the airway (36).”
BackgroundResultIncreased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma
Hasegawa, T., Uga, H., Mori, A., & Kurata, H. (2017) · European Cytokine Network · doi:10.1684/ecn.2017.0390 · Cited by 67
“have reported the dichotomous, mutually xclusive, pattern of Th2 and Th17 lymphocyte signaures by airway tissue gene expression analysis [41].”
Metadata
- Authors
- Choy, D. F., Hart, K. M., Borthwick, L. A., Shikotra, A., Nagarkar, D. R., Siddiqui, S., Jia, G., Ohri, C. M., Doran, E., Vannella, K. M., Butler, C. A., Hargadon, B., Sciurba, J. C., Gieseck, R. L., Thompson, R. W., White, S., Abbas, A. R., Jackman, J., Wu, L. C., Egen, J. G., Heaney, L. G., Ramalingam, T. R., Arron, J. R., Wynn, T. A., & Bradding, P.
- Affiliations
- Genentech (US)
- National Institutes of Health (US)
- Newcastle University (GB)
- University of Leicester (GB)
- Queen's University Belfast (GB)
- Corresponding author
- Choy, David F.
- Hart, Kevin M.
- Arron, Joseph R.
- Wynn, Thomas A.
- Bradding, Peter
- ORCID
- Choy, David F.
- Hart, Kevin M.
- Borthwick, Lee A.
- Nagarkar, Deepti R.
- Siddiqui, Salman
- Jia, Guiquan
- Doran, Emma
- Vannella, Kevin M.
- Butler, Claire A.
- Hargadon, Beverley
- Sciurba, Joshua C.
- Gieseck, Richard L.
- Abbas, Alexander R.
- Jackman, Janet
- Egen, Jackson G.
- Heaney, Liam G.
- Ramalingam, Thirumalai R.
- Arron, Joseph R.
- Wynn, Thomas A.
- Bradding, Peter
- Venue
- Science Translational Medicine
- Published
- 2015-08-19
- Volume
- 7
- Issue
- 301
- Pages
- 301ra129-301ra129
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2166997969
- Cited by
- 450
- References
- 63
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 26 · 2023: 34 · 2022: 41 · 2021: 42 · 2020: 71 · 2019: 46 · 2018: 48 · 2017: 46 · 2016: 48 · 2015: 5
- FWCI
- 36.11
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Funders
- NIH
- NIAID
- Genentech Inc.
- National Institute for Health Research
- Asthma UK (AUK-PG-2013-208)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- asthma, type 2 inflammation, Th17 inflammation, IL-13, IL-17A, IL-4, asthma endotypes, neutrophilic inflammation, eosinophilia, airway hyperresponsiveness, allergic asthma, combination therapy, cytokine neutralization
- MeSH terms
- Animals, Asthma, Cells, Cultured, Female, Humans, Mice, Inbred BALB C, Signal Transduction, Th2 Cells, Interleukin-13, Interleukin-17, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.